SCHEMBL827552

SCHEMBL827552

O=S(=O)(/C=C/c1ccc(F)cc1)Nc1ccccc1

nearest known ligand 0.88

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.88
PKM P14618 1/20 0.88
LMNA P02545 3/20 0.59
ALDH1A1 P00352 6/20 0.57
PTGES2 Q9H7Z7 5/20 0.53
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
NFE2L2 Q16236 1/20 0.50
HTT P42858 1/20 0.50
SCN9A Q15858 1/20 0.49
POLB P06746 2/20 0.49
MEN1 O00255 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL827553 1.00 KMT2A (0.88) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL1122935 0.93 KMT2A (1.00) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL1122427 0.88 KMT2A (0.77) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL1122431 0.88 KMT2A (0.77) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL827377 0.84 KMT2A (0.72) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL827378 0.84 KMT2A (0.72) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL1122567 0.84 KMT2A (0.72) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL826343 0.83 KMT2A (0.62) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL827960 0.83 KMT2A (0.62) KMT2APKMLMNAALDH1A1PTGES2
SCHEMBL826342 0.83 KMT2A (0.62) KMT2APKMLMNAALDH1A1PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896401-B1 UNSATURATED SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES SYNTHESIS UNIV TEMPLE (US) 2013-04-10 EP claimed
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-05-14 US claimed
EP-1896401-B1 UNSATURATED SULFIDES, SULFONES, SULFOXIDES AND SULFONAMIDES SYNTHESIS UNIV TEMPLE (US) 2013-04-10 EP disclosed
US-8143453-B2 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis Temple University—Of the Commonwealth System of Higher Education (US) 2012-03-27 US disclosed
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124828-A1 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis SULT2A1, SULT1A1, ARSA KMT2A 2578/4885PKM 3996/4885LMNA 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.